Vimarsana
Biggest News Aggregation in the World

Page 8 - Roche Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Group Today - Breaking & Trending Today

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit - Vimarsana News

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

BCVA gains of +5.5 letters at 24 months in Cohort 4 patients BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion Maintenance or increases...

BioNTech Announces First Quarter 2024 Financial Results and Corporate Update | Company Announcement - Vimarsana News

BioNTech Announces First Quarter 2024 Financial Results and Corporate Update | Company Announcement

Investegate announcements from BioNTech Announces First Quarter 2024 Financial Results and Corporate Update

Durable lymph-node expansion improves vaccine responses against tumors - Vimarsana News

Durable lymph-node expansion improves vaccine responses against tumors

Each one of us has around 600 lymph nodes (LNs) – small, bean-shaped organs that house various types of blood cells and filter lymph fluid – scattered throughout our bodies.

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) - Vimarsana News

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Award Will Support 2nd Annual Spinal Cord Injury Investor Symposium To Be Held June 26 and 27, 2024 ...

Opthea : Quarterly Activity Report - Form 6-K - Vimarsana News

Opthea : Quarterly Activity Report - Form 6-K

Quarterly Activity Report Q3 FY24 Highlights • Completion of enrolment in first trial of sozinibercept's Phase 3 pivotal program...